{
  "company": {
    "name": "Alithea (Alithea Genomics / Alithea Bio)",
    "website": "https://alithea-bio.com/",
    "record": "https://startuphistory.org/c/alithea-bio.com"
  },
  "status": null,
  "history_since": "2026-09-16T16:37:10.000Z",
  "baseline": {
    "snapshot_id": "7b76f78402a08007e7d32c60be5ad8eeb291367d55c0a5f4a2c05b2d220fa427",
    "observed_at": "2026-09-16T16:37:10.000Z",
    "headline": "Leading the Future of Precision Immunotherapy",
    "description": "Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery, TCR validation & off-target safety profiling.",
    "evidence": "https://web.archive.org/web/20260916163710/https://alithea-bio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-04T11:17:05.208Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-04T11:17:05.208Z",
      "variants": [
        {
          "headline": "Leading the Future of Precision Immunotherapy",
          "subhead": "Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery, TCR validation & off-target safety profiling.",
          "observed_at": "2026-09-16T16:37:10.000Z",
          "evidence": "https://web.archive.org/web/20260916163710/https://alithea-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Leading the Future of Precision Immunotherapy",
          "subhead": "Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery, TCR validation & off-target safety profiling.",
          "observed_at": "2026-11-04T11:17:05.208Z",
          "evidence": "https://alithea-bio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Leading the Future of Precision Immunotherapy",
      "subhead": "Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery, TCR validation & off-target safety profiling.",
      "from": "2026-09-16T16:37:10.000Z",
      "to": "2026-11-04T11:17:05.208Z",
      "captures": 2,
      "evidence": "https://alithea-bio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-09-16T16:37:10.000Z",
          "to": "2026-11-04T11:17:05.208Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Alithea (Alithea Genomics / Alithea Bio)” company record, https://startuphistory.org/c/alithea-bio.com"
}